Toll-like Receptor Agonist CBLB502 Protects Against Radiation-induced Intestinal Injury in Mice

Toll 样受体激动剂 CBLB502 可预防小鼠放射性肠道损伤

阅读:14
作者:Qiong Wang, Junzhao Duan, Jian Hong, Kexin Ding, Fumin Tai, Jie Zhu, Hanjiang Fu, Xiaofei Zheng, Changhui Ge

Aim

The small intestine is one of the organs most vulnerable to ionizing radiation (IR) damage. However,

Conclusion

This study preliminarily describes the regulatory mechanism of IR-induced intestinal injury and the potential molecular protective mechanism of CBLB502, providing a basis for identifying the functional genes and molecular mechanisms that mediate protection against IR-induced injury.

Methods

Mice were administered 0.2 mg/kg CBLB502 before IR at different doses for different time points, and then the survival rate, body weight, hemogram, and histopathology of the mice were analyzed.

Results

CBLB502 reduced IR-induced intestinal injury. RNA-seq analysis revealed that different doses and durations of IR induced different regulatory patterns. CBLB502 protected against intestinal injury mainly after IR by reversing the expression of IR-induced genes and regulating immune processes and metabolic pathways.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。